OFDT Documentation

  • Recherche
    • Recherche simple
    • Périodiques
    • Publications OFDT
    • Textes législatifs
    • Nos dernières publications
  • Sélections
    • Usages de drogues à l’adolescence
    • Usages de drogues féminins
    • Drogues et sécurité routière
    • Addictions en milieu professionnel
    • Addictions en milieu carcéral
  • À propos
    • Présentation
    • Contact
Aide

Rechercher

Aide

Recherche avancée

Périodiques

Portail documentaire

  • A-
  • A
  • A+

Site OFDT

Historique

Accès réservé à l'OFDT et ses partenaires



Mot de passe oublié ?
  • Recherche
    • Recherche simple
    • Périodiques
    • Publications OFDT
    • Textes législatifs
    • Nos dernières publications
  • Sélections
    • Usages de drogues à l’adolescence
    • Usages de drogues féminins
    • Drogues et sécurité routière
    • Addictions en milieu professionnel
    • Addictions en milieu carcéral
  • À propos
    • Présentation
    • Contact

Rechercher

Aide

Recherche avancée

Périodiques

  1. Accueil
  2. Retour
Nouvelle recherche Votre compte

Auteur B. PARDO

Documents disponibles écrits par cet auteur (14)

  Tris disponibles Ajouter le résultat à votre sélection
  Affiner la recherche
Nouveauté
Can new psychoactive substances be regulated effectively? An assessment of the British Psychoactive Substances Bill [Addiction debate]

Can new psychoactive substances be regulated effectively? An assessment of the British Psychoactive Substances Bill [Addiction debate]

P. REUTER ; B. PARDO | 2017
Dans Addiction (Vol.112, n°1, January 2017) Article : Périodique
The regulation of new psychoactive substances (NPS) has confounded governments throughout the western world. In 2014 the UK government convened an NPS Review Expert Panel to consider a range of approaches. Ultimately the Panel recommended that t[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
Cannabis policy reforms in the Americas: A comparative analysis of Colorado, Washington, and Uruguay

Cannabis policy reforms in the Americas: A comparative analysis of Colorado, Washington, and Uruguay

B. PARDO | 2014
Dans International Journal of Drug Policy (Vol.25, n°4, July 2014) Article : Périodique
Legal reforms in the Americas are influencing the public debate on cannabis policy. Uruguay and the two US states of Colorado and Washington have taken steps to regulate and legitimize the production, distribution, and use of cannabis and its de[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
A comparison of the world's first three jurisdictions to legally regulate marijuana: Colorado, Washington and Uruguay

A comparison of the world's first three jurisdictions to legally regulate marijuana: Colorado, Washington and Uruguay

Drug Policy Alliance ; A. A. GUTIÉRREZ ; B. PARDO | 2014
Rapport
In 2012, Colorado and Washington State became the first two jurisdictions to legally regulate marijuana, followed by Uruguay becoming the first country to do so in 2013. This table provides a comparison of the main elements of each jurisdiction'[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Considering heroin-assisted treatment and supervised drug consumption sites in the United States

Considering heroin-assisted treatment and supervised drug consumption sites in the United States

B. KILMER ; J. TAYLOR ; J. P. CAULKINS ; P. A. MUELLER ; A. J. OBER ; B. PARDO ; R. SMART ; L. STRANG ; P. H. REUTER | 2018
Rapport
Current levels of opioid-related morbidity and mortality in the United States are staggering. Data for 2017 indicate that there were more than 47,000 opioid-involved overdose deaths, and one in eight adults now reports having had a family member[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Contemporary Asian drug policy: Insights and opportunities for change

Contemporary Asian drug policy: Insights and opportunities for change

B. PARDO ; B. KILMER ; W. HUANG | 2019
Rapport
Changing patterns in drug use and supply can affect the well-being and development of Asian countries in many ways: The burden of disease from injection drug use, overreliance on the criminal justice system, and rise of drug-related crime can im[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Evolution of the U.S. overdose crisis. Understanding China's role in the production and supply of synthetic opioids

Evolution of the U.S. overdose crisis. Understanding China's role in the production and supply of synthetic opioids

B. PARDO | 2018
Rapport
The introduction of illicitly manufactured synthetic opioids to U.S. drug markets presents new challenges for contemporary drug policy: The potency of many synthetic opioids increases risk to users and poses challenges for first responders, the [...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Imagining a fentanyl future: Some consequences of synthetic opioids replacing heroin

Imagining a fentanyl future: Some consequences of synthetic opioids replacing heroin

P. REUTER ; B. PARDO ; J. TAYLOR | 2021
Dans International Journal of Drug Policy (Vol.94, August 2021) Article : Périodique
For nearly a century heroin has dominated the illegal opioid trade. The global supply of heroin is estimated to generate tens of billions of dollars in revenues a year and its illegal use has long been the source of many societal harms. The arri[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Intensity of cannabis use: Findings from three online surveys

Intensity of cannabis use: Findings from three online surveys

J. P. CAULKINS ; B. PARDO ; B. KILMER | 2020
Dans International Journal of Drug Policy (Vol.79, May 2020) Article : Périodique
Background: Drug use is often measured in terms of prevalence, meaning the number of people who used any amount in the last month or year, but measuring the quantity consumed is critical for making informed regulatory decisions and estimating th[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
Modelling the amount of inputs needed for methamphetamine manufacture in Afghanistan

Modelling the amount of inputs needed for methamphetamine manufacture in Afghanistan

B. PARDO ; A. NOBAJAS GANAU ; I. ZEILER | 2024
Dans Addiction (Vol.119, n°6, June 2024) Article : Périodique
BACKGROUND AND AIMS: The use and manufacture of methamphetamine has increased in Afghanistan in recent years. Recent research and reports have pointed to the ephedra plant, which grows wildly, as a key source of ephedrine used in the manufacture[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe
Nouveauté
New psychoactive substances: Are there any good options for regulating new psychoactive substances?

New psychoactive substances: Are there any good options for regulating new psychoactive substances?

P. REUTER ; B. PARDO | 2017
Dans International Journal of Drug Policy (Vol.40, February 2017) Article : Périodique
Advances in chemistry, technology, and globalization have contributed to the rapid development and diffusion of NPS (new psychoactive substances), creating perhaps the most serious challenge to the century-old international drug control system a[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
Supervised consumption sites: a nuanced assessment of the causal evidence [Addiction opinion and debate]

Supervised consumption sites: a nuanced assessment of the causal evidence [Addiction opinion and debate]

J. P. CAULKINS ; B. PARDO ; B. KILMER | 2019
Dans Addiction (Vol.114, n°12, December 2019) Article : Périodique
BACKGROUND AND AIMS: Supervised consumption sites (SCS) operate in more than 10 countries. SCS have mostly emerged as a bottom-up response to crises, first to HIV/AIDS and now overdose deaths, in ways that make rigorous evaluation difficult. Opi[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
Supplying synthetic opioids during a pandemic: An early look at North America [Commentary]

Supplying synthetic opioids during a pandemic: An early look at North America [Commentary]

B. PARDO | 2021
Dans International Journal of Drug Policy (Vol.93, July 2021) Article : Périodique
International commerce and travel have been restricted in order to limit the spread of COVID-19. The illegal trafficking in drugs, which is often concealed in other commercial activity, will be affected by these disruptions. This is particularly[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
The dawn of a new synthetic opioid era: the need for innovative interventions [Addiction Opinion and Debate]

The dawn of a new synthetic opioid era: the need for innovative interventions [Addiction Opinion and Debate]

B. PARDO ; J. TAYLOR ; J. CAULKINS ; P. REUTER ; B. KILMER | 2021
Dans Addiction (Vol.116, n°6, June 2021) Article : Périodique
BACKGROUND: Overdose deaths related to illegal drugs in North American markets are now dominated by potent synthetic opioids such as fentanyl, a circumstance foreshadowed by often-overlooked events in Estonia since the turn of the century. Marke[...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
The future of fentanyl and other synthetic opioids

The future of fentanyl and other synthetic opioids

B. PARDO ; J. TAYLOR ; J. P. CAULKINS ; B. KILMER ; P. REUTER ; B. D. STEIN | 2019
Rapport
Deaths involving synthetic opioids in the United States increased from roughly 3,000 in 2013 to more than 30,000 in 2018. In fact, synthetic opioids like fentanyl are now involved in twice as many deaths as heroin. This book offers a systematic [...]
Plus d'info
Ajouter à la sélection Ajouter à la sélection
open_link_url_notice Lien externe

première page page précédente 1 page suivante dernière page (1 - 14 / 14) Par page : 25 50 100 200

Contact

OFDT

69 rue de Varenne
75700 PARIS

Tel : (+33) 01 41 62 77 16

Accès rapides

  • L’établissement
  • Les partenaires
  • La lettre d’information

Avertissement

Toute inclusion dans la base documentaire ne vaut pas crédit scientifique de l'OFDT

Contact

OFDT

69 rue de Varenne
75700 PARIS

Tel : (+33) 01 41 62 77 16

Accès rapides

  • L’établissement
  • Les partenaires
  • La lettre d’information

Avertissement

Toute inclusion dans la base documentaire ne vaut pas crédit scientifique de l'OFDT

Suivez-nous

  • Traitement des données personnelles
  • Mentions légales
  • Plan du site